Diagnosis is confirmed by genetic testing, which is important due to the possibility of therapy in 33% of MoCoD patients with a mutation in the MOCS1 gene [66]. Here, MOCS1 is linked to sulfite oxidase deficiency due to molybdenum cofactor deficiency.